Neuraxial anesthesia for cesarean delivery: what criteria define the "optimal" technique?
Dan
D
Benhamou
Cynthia
C
Wong
D000767:Anesthesia, Epidural / Q000009:adverse effects; D000773:Anesthesia, Obstetrical / Q000009:adverse effects; D000775:Anesthesia, Spinal / Q000009:adverse effects; D000779:Anesthetics, Local / Q000008:administration & dosage* / Q000009:adverse effects; D002045:Bupivacaine / Q000008:administration & dosage* / Q000009:adverse effects; D002585:Cesarean Section; D004305:Dose-Response Relationship, Drug; D017558:Elective Surgical Procedures; D005260:Female; D006801:Humans; D007022:Hypotension / Q000139:chemically induced / Q000517:prevention & control; D018579:Patient Selection; D020250:Postoperative Nausea and Vomiting / Q000139:chemically induced / Q000517:prevention & control; D011247:Pregnancy; D012684:Sensory Thresholds / Q000187:drug effects; D013997:Time Factors
D000779:Anesthetics, Local; D002045:Bupivacaine